Noninvasive Testing for Colorectal Cancer: A Review

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Gastroenterology

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2005.41427.xPMID 15929776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Detection of APC, K-ras, and p53 Mutations in the Serum of Colorectal Cancer Patients as Circulating Biomarkers

  2004cited by this paper
• Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

  2004cited by this paper
• Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.

  2004cited by this paper
• Cancer Statistics, 2004

  2004cited by this paper
• Liver fatty acid binding protein expression in colorectal neoplasia

  2004cited by this paper
• Proteome analysis of human colon cancer by two‐dimensional difference gel electrophoresis and mass spectrometry

  2004cited by this paper
• A smarter strategy? Reflections on fecal DNA screening for colorectal cancer.

  2004cited by this paper
• Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

  2004cited by this paper
• Re: diagnostic potential of serum proteomic patterns in prostate cancer.

  2004cited by this paper
• Debate rages over proteomic patterns.

  2004cited by this paper
• Use of proteomic patterns to screen for gastrointestinal malignancies.

  2004cited by this paper
• Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps

  2004cited by this paper
• Rules of evidence for cancer molecular-marker discovery and validation

  2004cited by this paper
• Fecal multiple molecular tests to detect colorectal cancer in stool.

  2003cited by this paper
• A Randomised Trial of the Impact of New Faecal Haemoglobin Test Technologies on Population Participation in Screening for Colorectal Cancer

  2003cited by this paper
• Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer

  2003cited by this paper
• Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia

  2003cited by this paper
• Quantification of human intestinal gene expression profiles using exfoliated colonocytes: a pilot study

  2003cited by this paper
• Colorectal cancer screening: scientific review.

  2003cited by this paper
• Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.

  2003cited by this paper
• Prescreening Evaluation of a Brush-Based Faecal Immunochemical Test for Haemoglobin

  2003cited by this paper
• Diagnostic potential of serum proteomic patterns in prostate cancer.

  2003cited by this paper
• DNA integrity as a potential marker for stool-based detection of colorectal cancer.

  2003cited by this paper
• Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based detection of microsatellite instabilities in coding DNA sequences: a novel approach to identify DNA-mismatch repair-deficient cancer cells.

  2003cited by this paper
• Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers

  2003cited by this paper
• A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population

  2003cited by this paper
• Early detection: Proteomic applications for the early detection of cancer

  2003cited by this paper
• Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.

  2003cited by this paper
• Screening for Colorectal Cancer: Recommendation and Rationale

  2002cited by this paper
• Isolation of exfoliated colonocytes from human stool as a new technique for colonic cytology

  2002cited by this paper
• Screening for colorectal cancer: recommendation and rationale.

  2002cited by this paper
• Identification of nuclear matrix protein alterations associated with human colon cancer.

  2002cited by this paper
• Stool DNA analysis for the detection and follow-up of Colorectal Cancer (CRC) and Advanced Adenomas (AA): sensitivity in a prospective series

  2002cited by this paper
• Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

  2002cited by this paper
• Faecal calprotectin: a marker of inflammation throughout the intestinal tract

  2002cited by this paper
• Faecal calprotectin: a marker of inflammation throughout the intestinal tract

  2002cited by this paper
• Stool screening for colorectal cancer: evolution from occult blood to molecular markers.

  2002cited by this paper
• Detection of APC mutations in fecal DNA from patients with colorectal tumors.

  2002cited by this paper
• K- ras Mutations in Sera of Patients with Colorectal Neoplasias and Long-standing Inflammatory Bowel Disease

  2002cited by this paper
• Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool.

  2002cited by this paper
• Detection of proximal colorectal cancers through analysis of faecal DNA.

  2002cited by this paper
• Nuclear matrix protein alterations associated with colon cancer metastasis to the liver.

  2002cited by this paper
• Detection of Tumor DNA in Serum of Colorectal Cancer Patients

  2002cited by this paper
• Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells.

  2002cited by this paper
• Stool-based DNA tests for colorectal cancer: clinical potential and early results.

  2002cited by this paper
• Serum proteomic patterns for detection of prostate cancer.

  2002cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Stool DNA-based colorectal cancer detection: finding the needle in the haystack.

  2001cited by this paper
• Usefulness of galactose oxidase-Schiff test in rectal mucus for screening of colorectal malignancy.

  2001cited by this paper
• Detecting colorectal cancer in stool with the use of multiple genetic targets.

  2001cited by this paper
• Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.

  2001cited by this paper
• Meta-analysis of dietary restriction during fecal occult blood testing.

  2001cited by this paper
• Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer

  2001cited by this paper
• Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

  2001cited by this paper
• A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy

  2000cited by this paper
• Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

  2000influential reference
• K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.

  2000cited by this paper
• Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA.

  2000cited by this paper
• The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer

  2000cited by this paper
• Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.

  2000cited by this paper
• Molecular Detection of Codon 12 K-RAS Mutations in Circulating DNA from Serum of Colorectal Cancer Patients

  2000cited by this paper
• Gene therapy for liver cirrhosis

  2000cited by this paper
• Detection of upper gastrointestinal blood with fecal occult blood tests

  1999cited by this paper
• Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.

  1999cited by this paper
• Eliminating the Need for Dietary Restrictions When Using a Sensitive Guaiac Fecal Occult Blood Test

  1999cited by this paper
• Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

  1999cited by this paper
• Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.

  1998cited by this paper
• Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.

  1998cited by this paper
• Identification of nuclear matrix protein alterations associated with renal cell carcinoma.

  1998cited by this paper
• Fecal occult blood testing for colorectal cancer. Can we afford to do this?

  1997cited by this paper
• Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck.

  1997cited by this paper
• Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. American College of Physicians.

  1997cited by this paper
• Performance Characteristics and Comparison of Two Immunochemical and Two Guaiac Fecal Occult Blood Screening Tests for Colorectal Neoplasia

  1997cited by this paper
• Detection of colorectal neoplasia with peanut‐agglutinin(PNA)‐reactive carbohydrate structures in rectal mucus

  1997cited by this paper
• K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.

  1997cited by this paper
• Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer.

  1997cited by this paper
• A comparison of fecal occult-blood tests for colorectal-cancer screening.

  1996cited by this paper
• Bladder cancer-associated nuclear matrix proteins.

  1996cited by this paper
• A simple mucus test for cancer screening.

  1996cited by this paper
• Nuclear matrix proteins in human colon cancer.

  1994cited by this paper
• Nuclear matrix proteins in normal and breast cancer cells.

  1993cited by this paper
• Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects.

  1993cited by this paper
• Evaluation of a New Test for Colorectal Neoplasms: A Prospective Study of Asymptomatic Population

  1993cited by this paper
• Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

  1993cited by this paper
• Mucin glycoproteins in gastrointestinal malignancies and metastasis : Mucus glycoproteins in the gastrointestinal tract

  1993cited by this paper
• Mucin degradation in the human gastrointestinal tract and its significance to enteric microbial ecology

  1993cited by this paper
• Fecal occult blood testing for colorectal cancer.

  1992cited by this paper
• Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

  1992cited by this paper
• Fecal protein markers of colorectal cancer.

  1992cited by this paper
• Readability and sensitivity of a new faecal occult blood test in a hospital ward environment: Comparison with an established test

  1992cited by this paper
• Detection of nuclear matrix proteins in serum from cancer patients.

  1992cited by this paper
• Fecal lysozyme: an unreliable marker for colorectal cancer.

  1992cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• A pilot study on the usefulness of a new test for mass screening of colorectal cancer in Japan

  1990cited by this paper
• Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns.

  1990cited by this paper
• Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• Expression of carcinoembryonic antigen, T-antigen, and oncogene products as markers of neoplastic and preneoplastic colonic mucosa.

  1987cited by this paper
• ELISA for occult faecal albumin.

  1987cited by this paper
• Carcinoembryonic antigen.

  1986cited by this paper

• Ultrasensitive and label-free detection of piR-54265 biomarker by solution-gated graphene transistors with poly-adenine DNA assembled probe for accurate diagnosis of colorectal cancer

  2026cites this paper
• Cost effectiveness analysis of three colorectal cancer screening modalities in Kuwait

  2025cites this paper
• Unravelling the Role of Biomarker in Cancer Detection: An In-Depth Review

  2025cites this paper
• The Diagnosis Significance of Serum Cysteine Protease Inhibitors (CST4) in Colorectal Cancer

  2023cites this paper
• An updated review of the methods, guidelines of, and controversies on screening for colorectal cancer.

  2022cites this paper
• Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low Penetrance Genes

  2021cites this paper
• Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy

  2021cites this paper
• Cost-Effectiveness Analysis of Colorectal Cancer Screening: A Systematic Review

  2020cites this paper
• Cost-Effectiveness Analysis of Colorectal Cancer Screening: A Systematic Review

  2020cites this paper
• CCS

  2020cites this paper
• Colon Cancer: A Clinician’s Perspective in 2019

  2020cites this paper
• The future of cancer screening after COVID‐19 may be at home

  2020cites this paper
• Cost-Effectiveness Analysis of Colorectal Cancer Screening: A Systematic Review

  2020cites this paper
• Colorectal cancer-screening program improves both short- and long-term outcomes: a single-center experience in Trieste

  2020cites this paper
• Colon Cancer Screening

  2020cites this paper
• Cytomegalovirus Infection Is a Risk Factor in Gastrointestinal Cancer: A Cross-Sectional and Meta-Analysis Study

  2020cites this paper
• Evolution of colorectal cancer screening research in the past 25 years: text-mining analysis of publication trends and topics

  2020cites this paper
• Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults

  2019cites this paper
• The mechanistic link between type 2 diabetes and colorectal cancer

  2019cites this paper
• Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm

  2018cites this paper
• Enhanced uptake and improved anti‐tumor efficacy of doxorubicin loaded fibrin gel with liposomal apatinib in colorectal cancer

  2018cites this paper
• FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.

  2018cites this paper
• Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers

  2018cites this paper
• Diagnostic Fecal Occult Blood Testing in Hospitalized and Emergency Department Patients: Time for Change?

  2018cites this paper
• Luminally expressed gastrointestinal biomarkers

  2017cites this paper
• Which Fecal Immunochemical Test Should I Choose?

  2017cites this paper
• Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy

  2017cites this paper
• Investigating uptake in faecal immunochemical test (FIT) based colorectal cancer screening

  2017cites this paper
• Increasing Cystatin C and Cathepsin B in Serum of Colorectal Cancer Patients.

  2017cites this paper
• Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer

  2016cites this paper
• Biomarker detection technologies and future directions.

  2016cites this paper
• Early detection of colorectal cancer: from conventional methods to novel biomarkers

  2016influential citation
• Colorectal Cancer : Exploring Awareness in Lebanon

  2016cites this paper
• How to Minimize Groin Bulging after Herniorrhaphy

  2016cites this paper
• Advances in colonoscopy and screening for colon cancer

  2016cites this paper
• Precision Surgery and Surgical Spectroscopy

  2016cites this paper
• Integrating clinicopathological and molecular data in the breast cancer patient : towards precision medicine

  2016cites this paper
• In vitro selection of fluorogenic RNA-cleaving DNAzymes for colorectal cancer detection

  2016cites this paper
• Global Cancer Incidence and Mortality Rates and Trends—An Update

  2015cites this paper
• A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.

  2015cites this paper
• Colorectal Cancer Biomarkers: Where Are We Now?

  2015cites this paper
• Circulating cell-free microRNAs as biomarkers for colorectal cancer

  2015cites this paper
• Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.

  2015cites this paper
• The iKnife: real time Intra-operative tissue diagnostics using rapid evaporative ionisation mass spectrometry

  2015cites this paper
• Intestinal-specific activatable Myb initiates colon tumorigenesis in mice

  2015cites this paper
• Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme

  2014cites this paper
• Increasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010

  2014cites this paper
• Non-invasive fecal metabonomic detection of colorectal cancer

  2014cites this paper
• A Metabolic Study on Colon Cancer Using 1H Nuclear Magnetic Resonance Spectroscopy

  2014cites this paper
• Simultaneous Detection of Nucleic Acid and Protein Using Gold Nanoparticles and Lateral Flow Device

  2014cites this paper
• Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence

  2014cites this paper
• Diagnostic value of fecal calprotectin as a screening biomarker for gastrointestinal malignancies.

  2014cites this paper
• Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer.

  2014cites this paper
• In persons at average risk, stool DNA tests had higher sensitivity than FIT for detecting colorectal cancer

  2014cites this paper
• Validación de técnica inmunoquímica para detección de sangre oculta en heces

  2014cites this paper
• Validation of an immunochemical technique for the detection of fecal occult blood

  2014cites this paper
• Health Disparities in Colorectal Cancer Screening in The United States: Race/ethnicity or Shifting Paradigms?

  2013cites this paper
• Effectiveness of the immunochemical fecal test (FIT) for detection of advanced adenomas in colorectal carcinoma screening in an asymptomatic population.

  2013influential citation
• Chapter 2 Molecular screening to colorectal cancer Adapted from : Molecular tests for colorectal cancer screening

  2013cites this paper
• Colorectal cancer screening: From test performance to participant experience

  2013cites this paper
• Results of faecal immunochemical test for colorectal cancer screening, in average risk population, in a cohort of 1389 subjects

  2013cites this paper
• Associations between cholesterol, colon cancer screening, behavior, and diet.

  2013cites this paper
• Global Microrna Gene Expression Profiles Analysis And Possible Role Of Microrna-5p And 3p Pairs In Human Colon Cancer Cells

  2013cites this paper
• The role of the innate immune system in microbially induced intestinal inflammation and neoplasia

  2013cites this paper
• National program of colorectal carcinoma early detection in Brod-Posavina County (east Croatia).

  2013cites this paper
• Review of biomarkers in colorectal cancer

  2012cites this paper
• Digital detection of multiple minority mutants in stool DNA for noninvasive colorectal cancer diagnosis.

  2012cites this paper
• The Diagnostic, Prognostic, and Predictive Potential of MicroRNA Biomarkers in Colorectal Cancer

  2012cites this paper
• Diagnostic Utility of Flexible SigmoidoscopyAs An Aid In Diagnosis of Colorectal Disease

  2012cites this paper
• Detección de hemoglobina humana en heces

  2011cites this paper
• A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection

  2011cites this paper
• Molecular tests for colorectal cancer screening.

  2011cites this paper
• Noninvasive Screening Tests

  2011influential citation
• 9 – Stool and Blood Sampling for Early Detection of Colorectal Cancer

  2011cites this paper
• Fecal Occult Blood Test

  2011cites this paper
• The discovery and validation of colorectal cancer biomarkers.

  2011influential citation
• Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals

  2011cites this paper
• Assessment of novel combinations of biomarkers for the detection of colorectal cancer

  2010cites this paper
• Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.

  2010cites this paper
• Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection

  2010cites this paper
• Effect of Verification Bias on the Sensitivity of Fecal Occult Blood Testing: a Meta-Analysis

  2010cites this paper
• Biological and clinical markers in colorectal cancer: state of the art.

  2010cites this paper
• Noninvasive detection of inflammation-associated colon cancer in a mouse model.

  2010cites this paper
• Knowledge and Beliefs of Jordanians Toward Colorectal Cancer Screening

  2010cites this paper
• Strategy for early detection of colon cancer

  2010cites this paper
• The Use of Molecular Markers in the Diagnosis of Colorectal Cancer Screening

  2010cites this paper
• Inter‐test agreement and quantitative cross‐validation of immunochromatographical fecal occult blood tests

  2010cites this paper
• Preliminary evaluation of a nanotechnology-based approach for the more effective diagnosis of colon cancers.

  2010cites this paper
• Performance improvements of stool-based screening tests.

  2010influential citation
• Effectiveness of the Immunofecal Occult Blood Test for Colorectal Cancer Screening in a Large Population

  2010cites this paper
• Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer.

  2010cites this paper
• CAUSES AND TREATMENT FOR COLON AND LUNG CANCER.

  2010cites this paper
• Comparison of Immunochemical and Guaiac-Based Occult Fecal Tests with Colonoscopy Findings in Symptomatic Patients

  2009cites this paper
• [Influence of the pre-analytical specimen storage conditions on the fecal occult blood test results].

  2009cites this paper
• Fecal occult blood testing.

  2009cites this paper
• A systematic review of the literature June 2009 Comparison of diagnostic accuracy between immunochemical and guaiac based faecal occult blood tests for colorectal cancer detection Arindam

  2009cites this paper
• Clusterin in Stool: A New Biomarker for Colon Cancer Screening?

  2009cites this paper
• Identification of Cystatin SN as a novel tumor marker for colorectal cancer.

  2009cites this paper
• Comparison of conventional guaiac to four immunochemical methods for fecal occult blood testing: implications for clinical practice in hospital and outpatient settings.

  2009cites this paper
• Laboratory for Patients at Risk of Multiple Primary Malignancies

  2009cites this paper